About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Texas | 864 Studies

Clinical Trials Prostate CancerTexas

Prostate Cancer Clinical Trials in Texas

Find 864 clinical trials for prostate cancer near Texas. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Texas

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 581-600 of 864 trials

CompletedABI-008 Trial in Patients With Hormone-refractory Prostate CancerTo determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of ABI-008 given every 3 weeks; to characterize the toxicities of ABI-008; and to determine the…NCT00477529·Ann Arbor, Michigan and 3 others RecruitingThis is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid TumorsThis is a phase 1 dose escalation trial of ZM008, an anti-LLT1 antibody as a single agent followed by combination with Toripalimab in patients with advanced solid tumors who have…NCT06451497·Boston, Massachusetts and 2 others CompletedA Study to Evaluate Oral VT-464 in Patients With Castration-Resistant Prostate CancerThe goal of this clinical study is to determine the safety, tolerability, pharmacokinetics and activity of Seviteronel, a lyase-selective inhibitor of CYP17, in patients with…NCT02012920·Homewood, Alabama and 22 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedSafety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical FailureThe purpose of this phase II, randomized, double-blind placebo controlled, multi-center study is to evaluate the safety and efficacy of 10 mg atrasentan in hormone naive subjects…NCT00038662·Homewood, Alabama and 39 others

RecruitingFOG-001 in Locally Advanced or Metastatic Solid TumorsThe goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial…NCT05919264·Phoenix, Arizona and 32 others

CompletedPentoxifylline, Atorvastatin, and Vitamin E in Treating Patients With Erectile Dysfunction After Radiation Therapy for Prostate CancerThis phase II trial studies how well pentoxifylline, atorvastatin, and vitamin E (PAVE) work in treating patients with erectile dysfunction after radiation therapy for prostate…NCT03830164·Houston, Texas

TerminatedTo Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate CancerPhase 1b - To assess the safety/tolerability of VERU-111 and to determine the maximum tolerated dose of VERU-111 in patients with metastatic, castration resistant prostate cancer…NCT03752099·Golden, Colorado and 12 others

CompletedA Phase 1 Pilot Study of 99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men With Prostate CancerThis is a single arm, open label study of up to 24 prostate cancer patients scheduled for prostatectomy and/or pelvic lymph node dissection.NCT01615406·Houston, Texas

RecruitingStudy of ORIC-944 in Patients With Metastatic Prostate CancerThe purpose of this study is to establish the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic…NCT05413421·Colorado Springs, Colorado and 26 others

RecruitingStem Cells for Erectile Dysfunction Post RALPThis is a phase 1/2 single center, pilot study to assess safety and efficacy of allogeneic adipose-derived mesenchymal stem cells (HB-adMSCs) and to evaluate the timing and…NCT07048314·Houston, Texas

Completed64Cu-SAR-bisPSMA for Identification of Participants With Recurrence of Prostate Cancer (COBRA)The aim of this study is to determine the safety and efficacy of 64Cu-SAR-bisPSMA and determine the ability of 64Cu-SAR-bisPSMA Positron emission tomography (PET)/computed…NCT05249127·Los Angeles, California and 4 others

Not yet recruitingNeoadjuvant Intraprostatic OnabotulinumtoxinA Before Radical Prostatectomy for High-Risk Localized Prostate CancerThis pilot randomized, single-blind, placebo-controlled study evaluates the feasibility, safety, and preliminary biological activity of neoadjuvant intraprostatic…NCT07796490·Houston, Texas

CompletedToremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyAndrogen deprivation therapy (ADT) treatment for prostate cancer decreases the natural hormone called testosterone.NCT00129142·Homewood, Alabama and 154 others

Active not recruitingAndrogen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate CancerRATIONALE: Androgens can cause the growth of prostate cancer cells. Androgen deprivation therapy may stop the adrenal glands from making androgens.NCT01368588·Mobile, Alabama and 477 others

CompletedCelecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate CancerThe purpose of this study is to learn the effects (both good and bad) that celecoxib has on prostate cancer and patients with prostate cancer.NCT00136487·Hartford, Connecticut and 8 others

Active not recruitingStereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate CancerSince high risk prostate cancer requires higher radiation, this study is being done to determine the maximum tolerated dose of radiation to the prostate and pelvic regions.NCT02353819·Dallas, Texas

TerminatedEfficacy of Cancer Support Programs: A Social Comparison Theory AnalysisThe goal of this research study is to learn if a support group program is acceptable for patients with prostate cancer or patients with breast cancer.NCT00798187·Houston, Texas

CompletedSafety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based ChemotherapyThis is a phase 3 study to compare the clinical benefit of MDV3100 versus placebo in patients with castration-resistant prostate cancer who have been previously treated with…NCT00974311·Birmingham, Alabama and 248 others

CompletedAdenosine Receptor Antagonist Combination Therapy for Metastatic Castrate Resistant Prostate CancerThis is a Phase 1b/2, open-label, multicenter platform trial to evaluate the antitumor activity and safety of etrumadenant (AB928)-based combination therapy in participants with…NCT04381832·Cerritos, California and 18 others

RecruitingStudy Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCThe purpose of this study is to determine whether \[225Ac\]Ac-PSMA-617 (AAA817), given for up to 6 cycles at a dose of 10 Megabecquerel (MBq) +/- 10%, plus androgen receptor…NCT06855277·Homewood, Alabama and 105 others

PreviousPage 30 of 44Next

Other Conditions in Texas

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma